At a glance
- Originator Fujisawa
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 05 Jun 2001 This compound is still in active development
- 06 May 1998 An in vitro study has been added to the antimicrobial activity and pharmacodynamic sections
- 05 May 1998 New profile